A multi-tier platform architecture designed to integrate electronic health records has demonstrated the preliminary technical feasibility of secure rare disease data sharing within a simulated research environment. Reported by investigators Que Wu, Linyue Ma, and Tiantian Dong in Archives of Public Health, the prototype was developed to address persistent data silos across medical institutions by activating underutilized clinical documentation. The authors evaluated their proposed system using synthetic clinical records alongside the Chinese Biomedical Language Understanding Evaluation benchmark, systematically examining named entity recognition accuracy, blockchain write throughput, latency, and dynamic de-identification performance in controlled laboratory conditions.
The research addresses the persistent fragmentation of rare disease data, an ongoing challenge that significantly hinders medical investigations and orphan drug development worldwide.
To overcome substantial variations in medical terminology across disparate clinical environments, the multi-tier platform integrates dedicated clinical semantic standardization tools. The system architecture incorporates the domain-adapted natural language processing model Rare-RoBERTa together with standardized ORPHA-codes to establish uniform clinical semantic classifications across heterogeneous hospital records.
The technical performance of the information extraction pipeline was formally evaluated using the Chinese Biomedical Language Understanding Evaluation benchmark. In simulated data governance evaluations, Rare-RoBERTa achieved an overall F1-score of 87.3 percent in named entity recognition.
To manage secure data exchange without relying on mutual institutional trust, the platform prototype was implemented using the Hyperledger Fabric blockchain. This decentralized ledger architecture facilitates zero-trust, fully audited data transactions across participating healthcare institutions. During technical simulation experiments designed to evaluate system performance and scalability, the simulated blockchain network achieved a peak write throughput of approximately 980 transactions per second under a simulated workload of 600 concurrent users while investigators systematically assessed transaction latency and ledger processing capabilities under synthetic operational conditions.
Data governance and patient confidentiality were assessed through the platform’s dynamic privacy-preserving de-identification mechanism, which aims to protect sensitive personal health information while retaining analytical utility for downstream clinical research. In simulated evaluations using synthetic records, the de-identification procedure restricted the estimated re-identification risk to below 0.08 percent. Simultaneously, the mechanism maintained research data utility, incurring a measured information loss of 14.5 percent during the privacy-preserving transformation process.
The authors explicitly emphasized that all reported operational metrics represent simulated technical performance within a controlled laboratory environment and must not be interpreted as evidence of clinical effectiveness or operational scalability in live hospital environments. Although the proposed architecture outlines a plausible preliminary foundation to reactivate dormant clinical data and potentially support future health equity, the authors concluded that rigorous multi-center pilot trials using real-world heterogeneous electronic health records remain essential prior to real-world clinical deployment, ultimately facilitating evidence-based policymaking and rare disease governance.
Subject of Research: System architecture and simulation of a secure rare disease data-sharing platform
Article Title: Designing a secure rare disease data-sharing platform leveraging electronic health records: a system architecture and simulation study
Article References: Wu, Q., Ma, L., & Dong, T. (2026). Designing a secure rare disease data-sharing platform leveraging electronic health records: a system architecture and simulation study. Archives of Public Health. https://doi.org/10.1186/s13690-026-02138-0
Image Credits: AI Generated
DOI: 10.1186/s13690-026-02138-0
Keywords: rare disease data sharing, electronic health records, Hyperledger Fabric, Rare-RoBERTa, ORPHA-codes, clinical semantic standardization, named entity recognition, CBLUE benchmark, zero-trust architecture, data silos, dynamic de-identification, re-identification risk, write throughput, orphan drug development, synthetic clinical records, rare disease governance
News Source: Ophelia Keating. (November 13, 2026). Simulated Blockchain Platform Shows Feasibility for Secure Rare Disease Data Sharing. Scienmag.



